Insights on Clinical Trials

  1. Supporting The Clinical Journey From Discovery To Delivery 6/3/2025

    Clinical Trials Day celebrates the science and collaboration driving medical breakthroughs — discover how Cryoport Systems helps power this progress behind the scenes.

     

  2. Critical Imaging Risks In GLP-1 And Neurology Studies 5/27/2025

    As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that safeguards participant safety and supports robust, reproducible outcomes.

  3. Inside The Trials Aiming To Stop Vision Loss For Rare Eye Disease Patients 5/27/2025

    Ocugen Chief Medical Officer Huma Qamar, MD, MPH, CMI, discusses two rare disease trials and how the company's managed their protocol design, PI selection, and patient recruitment.

  4. Bayesian Study Designs In Early-Phase Oncology Trials 5/23/2025

    In response to insufficient traditional dose-escalation methods, regulatory initiatives like the FDA’s Project Optimus advocate for identifying optimal biological doses rather than relying solely on maximum tolerated doses (MTD).

  5. Optimizing Clinical Bridging Strategies For Combination Drug Products: A Risk-Based Approach 5/21/2025

    Clinical bridging studies demonstrate bioequivalence or bioavailability for drug-device combinations, using pharmacokinetic parameters and a risk-based, four-step approach to support regulatory approval and product transitions.

  6. Top Biotech Hubs Around The World: Where Innovation Thrives In 2025 5/20/2025

    Explore the leading biotech hubs in 2025, what makes them unique, and how companies can leverage these ecosystems to accelerate innovation and growth.

  7. Overview Of Obesity: Global Clinical Trials Landscape 5/20/2025

    This comprehensive overview of current and emerging obesity treatments provides insight into the growing global health crisis that is rising in prevalence across all demographics and income levels.

  8. IPF - Global Clinical Trial Landscape 5/19/2025

    This report provides a comprehensive overview of Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal interstitial lung disease.

  9. Commercializing Rare Disease Treatment With Near Real-Time Alerts 5/16/2025

    How did Quest help a leading pharmaceutical company overcome the data latency challenges associated with traditional EHR when recruiting eligible patients for a rare blood disorder drug?

  10. Infectious Diseases - Global Clinical Trial Landscape (2025) 5/14/2025

    The global infectious disease clinical trial landscape has rapidly expanded between 2020 and 2024, driven by the urgency of emerging threats, technological innovation, and evolving regulatory frameworks.